Substantial and increasing clinical, genetic, epidemiologic, and basic science evidence supports a central role of excess tumor necrosis factor-alpha (TNF-alpha) in the pathogenesis of Alzheimer's disease, suggesting that excess TNF-alpha is a therapeutic target [1-19]. Here, TNF is linked to early-onset autosomal dominant Alzheimer disease.